MISSO, Gabriella
 Distribuzione geografica
Continente #
EU - Europa 1.640
NA - Nord America 1.557
AS - Asia 242
AF - Africa 4
OC - Oceania 3
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.450
Nazione #
US - Stati Uniti d'America 1.553
IE - Irlanda 636
IT - Italia 280
GB - Regno Unito 184
UA - Ucraina 182
DE - Germania 138
CN - Cina 90
VN - Vietnam 72
FI - Finlandia 56
GR - Grecia 54
TR - Turchia 43
BE - Belgio 38
FR - Francia 33
SE - Svezia 28
PK - Pakistan 10
IR - Iran 9
IN - India 6
CA - Canada 4
JP - Giappone 4
KR - Corea 4
AU - Australia 3
BR - Brasile 3
NL - Olanda 3
SC - Seychelles 3
CZ - Repubblica Ceca 2
HK - Hong Kong 2
RU - Federazione Russa 2
AT - Austria 1
DK - Danimarca 1
EU - Europa 1
ID - Indonesia 1
KE - Kenya 1
MD - Moldavia 1
QA - Qatar 1
SI - Slovenia 1
Totale 3.450
Città #
Dublin 636
Chandler 308
Jacksonville 300
Ann Arbor 81
New York 73
Dong Ket 72
Ashburn 69
Princeton 69
Medford 61
Bremen 60
Roxbury 53
Beijing 48
Caserta 42
Brussels 38
Woodbridge 36
Wilmington 29
Naples 27
Des Moines 24
San Mateo 20
Napoli 19
Boardman 18
Mountain View 15
Aversa 11
Cambridge 11
San Nicola la Strada 10
Falls Church 8
Milan 8
Cava Dei Tirreni 7
Düsseldorf 6
Helsinki 6
Zhengzhou 6
Auburn Hills 5
Avellino 5
Houston 5
Nanjing 5
Rome 5
Boydton 4
Gunzenhausen 4
London 4
Bascape 3
Castellammare Di Stabia 3
Jinan 3
Norwalk 3
Nottingham 3
San Giorgio a Cremano 3
Santa Clara 3
Saviano 3
Tianjin 3
Washington 3
Brno 2
Capri 2
Castel Volturno 2
Forino 2
Groningen 2
Haikou 2
Hebei 2
Hefei 2
Hong Kong 2
Istanbul 2
Lappeenranta 2
Latina 2
Los Angeles 2
Melbourne 2
Prata 2
Pune 2
Redwood City 2
San Felice A Cancello 2
Seattle 2
Shanghai 2
Shenyang 2
Tricase 2
Vellore 2
Aigaleo 1
Caiazzo 1
Campania 1
Campobasso 1
Campodarsego 1
Capua 1
Catania 1
Cava de' Tirreni 1
Centro 1
Changsha 1
Clifton Park 1
Copenhagen 1
Doha 1
Edinburgh 1
Elora 1
Fairfield 1
Ferrara 1
Florence 1
Frattamaggiore 1
Giugliano In Campania 1
Grafing 1
Gragnano 1
Guangzhou 1
Hangzhou 1
Hanover 1
Hyderabad 1
Jiaxing 1
Jinhua 1
Totale 2.312
Nome #
Comparative study of NGS platform ion torrent personal genome machine and therascreen rotor-gene Q for the detection of somatic variants in cancer. 85
A miRNA signature suggestive of nodal metastases from laryngeal carcinoma. 81
W7FW14F apomyoglobin amyloid aggregates-mediated apoptosis is due to oxidative stress and AKT inactivation caused by Ras and Rac 79
miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma 76
Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment 73
"Phase II trial of bevacizumab and dose/dense chemoterapy with cisplatin and metronomic daily oral etoposide in advanced non small cell lung cancer patients" 70
Mitochondria as playmakers of apoptosis, autophagy and senescence 70
Emerging strategies to strengthen the anti-tumour activity of type I IFNs: overcoming survival pathways 67
Gene interference strategies as a new tool for the treatment of prostate cancer 67
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells 65
Prognostic value of EGFR and EGFR-MEDIATED transduction signal inhibition: effective therapeutic strategies in the management of laryngeal cancer 65
Evaluation of the in vitro and in vivo antiangiogenic effects of denosumab and zoledronic acid. 64
Transferrin-Conjugated SNALPs Encapsulating 2'-O-Methylated miR-34a for the Treatment of Multiple Myeloma 61
Cytotoxic drugs up-regulate Epidermal Growth Factor Receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted Antibody-Dependent-Cell-mediated-Cytotoxicity (ADCC) 59
Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery 58
Definition of microRNAs predictive of nodal involvement in laringeal cancer patients 58
Possible roles of transglutaminases in molecular mechanisms responsible for cancer and human neurodegenerative diseases. 58
Radiotherapy prolongs the survival of advanced non-smallcell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev) 58
Impact of anemia management with EPO on psychologic distress in cancer patients: results of a multicenter patient survey. 57
Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action 56
High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy. 55
Definition of miRNA Signatures of Nodal Metastasis in LCa: miR-449a Targets Notch Genes and Suppresses Cell Migration and Invasion 55
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 55
Core-shell biodegradable nanoassemblies for the passive targeting of docetaxel: features, antiproliferative activity and in vivo toxicity. 54
Possible antioxidant role of SPA therapy with chlorine-sulphur-bicarbonate mineral water. 53
Measurement of autophagy by flow cytometry 53
A hydroquinone-based derivative elicits apoptosis and autophagy via activating a ros-dependent unfolded protein response in human glioblastoma 53
Optimal Management of Prostate Cancer Based on its Natural Clinical History 52
Early detection of laryngeal cancer: prominence of miRNA signature as a new tool for clinicians 52
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1. 51
Tumour-specific uptake of anti-cancer drugs: the future is here. 51
MOLECULAR TARGETS FOR THE TREATMENT OF MULTIPLE MYELOMA 51
Bisphosphonates and cancer: what opportunities from nanotechnology? 51
Emerging pathways as individualized therapeutic target of multiple myeloma. 51
Combined use of free light chain and heavy/light chain ratios allow diagnosis and monitoring of patients with monoclonal gammopathies: Experience of a single institute, with three exemplar case reports 50
Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus 50
Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin 49
Myrtucommulone production by a strain of Neofusicoccum australe endophytic in myrtle (Myrtus communis). 49
Long non-coding RNAs as important biomarkers in laryngeal cancer and other head and neck tumours 48
Long-term neuropathic pain behaviors correlate with synaptic plasticity and limbic circuit alteration: a comparative observational study in mice 48
Urotensin-II receptor: a double identity receptor involved in vasoconstriction and in the development of digestive tract cancers and other tumors 47
Gemcitabine, oxaliplatin, levofolinate, 5-fluorouracil, granulocyte-macrophage colony-stimulating factor, and interleukin-2 (GOLFIG) versus FOLFOX chemotherapy in metastatic colorectal cancer patients: The GOLFIG-2 multicentric open-label randomized phase III trial 47
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 47
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 46
Zoledronic acid affects the cytotoxic effects of Chlamydia pneumoniae and the modulation of cytokine production in human osteosarcoma cells. 45
Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses 45
Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer 45
In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma. 44
Immune-modulating Effects of the Newest Cetuximab-based Chemoimmunotherapy Regimen in Advanced Colorectal Cancer Patients. 44
MicroRNAs’ Crucial Role in Salivary Gland Cancers’ Onset and Prognosis 44
Non Coding RNAs: A New Avenue for the Self-Tailoring of Blood Cancer Treatment 42
Insight toward the microRNA profiling of laryngeal cancers: Biological role and clinical impact 42
Breast Cancer Chemotherapeutic Options: A General Overview on the Preclinical Validation of a Multi-Target Ruthenium(III) Complex Lodged in Nucleolipid Nanosystems 41
Mir-34: a new weapon against cancer? 40
Poorly differentiated neuroendocrine larynx carcinoma: Clinical features and mirnas signature—a new goal for early diagnosis and therapy? 40
Pharmacological inhibition of HSP90 and ras activity as a new strategy in the treatment of HNSCC. 39
Role of perineural invasion as a prognostic factor in laryngeal cancer 38
Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem 38
Molecular markers as a new tool for diagnostic and prognostic definition of type 2 diabetes mellitus 37
Lipid Nanoparticles to Deliver miRNA in Cancer 37
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse 37
Synergistic activity of everolimus and 5-aza-2'-deoxycytidine in medullary thyroid carcinoma cell lines 37
Hepatocarcinoma: genetic and epigenetic features 34
Non-coding RNAs as a new dawn in tumor diagnosis 34
Clinical and Molecular Characteristics of Rare Malignant Tumors of Colon and Rectum 32
Strain Analysis in the Assessment of a Mouse Model of Cardiotoxicity due to Chemotherapy: Sample for Preclinical Research 31
Therapeutic targeting of miR-29b/HDAC4 epigenetic loop in multiple myeloma 30
Interleukin-2 and lanreotide in the treatment of medullary thyroid cancer: in vitro and in vivo studies. 29
The route to solve the interplay between inflammation, angiogenesis and anti-cancer immune response 29
MICRO-RNAs as biological markers for prevention and diagnosis of oral carcinomas 29
Prognostic patterns for predicting lymph node metastasis in patients with squamous cell carcinoma of the larynx 28
microRNA Detection via Nanostructured Biochips for Early Cancer Diagnostics 19
Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer 18
Safety and efficacy evaluation in vivo of a cationic nucleolipid nanosystem for the nanodelivery of a ruthenium(Iii) complex with superior anticancer bioactivity 17
Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics 16
Genetic landscape of colorectal cancer patients manifesting tumor shrinkage during SARS-Cov-2 infection 11
Tumour Burden Reporting in Phase III Clinical Trials of Metastatic Lung, Breast, and Colorectal Cancers: A Systematic Review 11
MiR-449a antagonizes EMT through IL-6-mediated trans-signaling in laryngeal squamous cancer 10
Triple Negative Breast Cancer Preclinical Therapeutic Management by a Cationic Ruthenium-Based Nucleolipid Nanosystem 10
Identification of Tissue miRNA Signatures for Pancreatic Ductal Adenocarcinoma 4
Nanoparticelle e loro usi 4
Biosensore per rivelazione di firma molecolare di miRNA ad interesse diagnostico in patologie umane 3
Aminobisphosphonates and nano technologically-modified aminobisphosphonates: A new dawn in the treatment of bone and extra-bone tumors? 1
Totale 3.680
Categoria #
all - tutte 12.008
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.008


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201952 0 0 0 0 0 0 0 0 14 1 21 16
2019/2020439 96 60 8 13 63 11 77 22 26 21 29 13
2020/2021525 39 6 57 27 60 13 64 47 29 42 61 80
2021/2022444 23 12 1 7 147 11 6 14 18 25 43 137
2022/20231.228 125 19 18 118 104 121 8 65 582 22 26 20
2023/2024496 43 18 92 31 163 82 7 23 37 0 0 0
Totale 3.680